Latanoprost Completed Phase 2 Trials for Glaucoma or Ocular Hypertension and / Glaucoma / Ocular Surface Disease / Ocular Hypertension Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01254370Safety and Efficacy Study of CatioprostĀ® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan ZĀ® to Treat Glaucoma and Ocular Surface Disease
NCT00845299Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
NCT00820300A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma
NCT01302249AR-12286 in Combination With Latanoprost
NCT00650702Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT01481077A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
NCT01481051A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
NCT00572936Circadian Rhythms of Aqueous Humor Dynamics in Humans
NCT01060579Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure
NCT02466399POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma